Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone

IMPORTANCE: Recently, genetic polymorphism in HSD3B1 encoding 3β-hydroxysteroid dehydrogenase-1 has been shown to be associated with oncological outcome when treated with androgen-deprivation therapy (ADT) for prostate cancer. Upfront abiraterone combined with ADT has proved survival benefit. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiota, Masaki, Narita, Shintaro, Akamatsu, Shusuke, Fujimoto, Naohiro, Sumiyoshi, Takayuki, Fujiwara, Maki, Uchiumi, Takeshi, Habuchi, Tomonori, Ogawa, Osamu, Eto, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484618/
https://www.ncbi.nlm.nih.gov/pubmed/30794306
http://dx.doi.org/10.1001/jamanetworkopen.2019.0115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484618/
https://www.ncbi.nlm.nih.gov/pubmed/30794306
http://dx.doi.org/10.1001/jamanetworkopen.2019.0115

Ejemplares similares